Skintelligence

Clinical Decision Support Systems for Biological Therapy Recommendations

Health Tech & Life Sciences
Non Active, Dec 2021 ceased to operate
Pre-Funding Jerusalem, Israel Founded 2018
Last updated 2026-06-18
Total raised
Last: Grant 2018-12
Stage
Pre-Funding
Founded
2018
Headcount
5
HQ
Jerusalem, Israel
Sector
Health Tech & Life Sciences

About

Skintelligence is the developer of clinical decision support systems (CDSSs) designed to predict an individuals response to biological therapy, specifically in the treatment of autoimmune diseases such as psoriasis, rheumatoid arthritis, and Crohns disease. The companys solution enables physicians to prescribe biological medication while avoiding the typical process of trial and error, thereby reducing both the high cost of biological treatments and the patients discomfort. Skintelligences CDSSs are based on artificial intelligence tools that enable the compilation of information fundamental to predicting a patients response to therapy. The companys patented SmartPAD (SMART Predictor for Autoimmune Diseases) comprises a device that measures immunologic biomarkers from the skin using non-invasive assays and software that integrates the biomarkers from the skin with clinical data to calculate the probability of treatment success with each of the commercial biological drugs.

Funding history · 1 round · — total

2018-12
Grant Undisclosed

Q&A

What is Skintelligence's primary focus?
Skintelligence develops clinical decision support systems (CDSSs) to predict individual responses to biological therapy for autoimmune diseases like psoriasis, rheumatoid arthritis, and Crohn's disease.
When was Skintelligence founded?
Skintelligence was founded in April 2018.
What is the current status of Skintelligence?
Skintelligence is currently inactive, having ceased operations in December 2021.
How many employees does Skintelligence have?
Skintelligence has 1-10 employees.
Has Skintelligence received any funding?
Yes, Skintelligence received a Grant round of funding in December 2018 from Israel Innovation Authority.
What technology does Skintelligence utilize in its solutions?
Skintelligence's CDSSs are based on artificial intelligence and machine learning tools.
Does Skintelligence hold any patents?
Yes, Skintelligence holds one patent for its SmartPAD (SMART Predictor for Autoimmune Diseases) system.
Who are the founders of Skintelligence?
The founders of Skintelligence include Miriam Oron (Managing Director & CEO), Guy Shalom (CMO), Meital Portugal (CSO), Moshe Amitay (CTO), and Zohar Barnett-Itzhaki (Chief of Bioinformatics).

Team · 5

miriam oron
Founder · Managing Director & CEO
LinkedIn ↗
Guy Shalom
Founder · CMO
Founder · CSO
LinkedIn ↗
Founder · CTO
LinkedIn ↗
Founder · Chief of Bioinformatics
LinkedIn ↗

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesDigital HealthcareMedical Decision Support
Technologies
Artificial IntelligenceMachine Learning
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticalsHealthcareProvidersFinancial ServicesFinancial ProductsInsurance
Business model
B2B

Highlights

1 PatentsVerified

Tags

personalizationnon-invasivedigital-healthcaremedical-devicescrohn-s-diseasedoctorspharma-companiestreatmentsmachine-learningartificial-intelligencedecision-supportskin-caresaasinsurance-companiesautoimmune-diseasesbiomarkersclinicsbioconvergence
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

Identifiers & details

Founded2018-4
Employees (exact)5
Status reasonNon Active, Dec 2021 ceased to operate